Status: current, Defined. Date: 30-Apr 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4808871000168118 | PKU Sphere20 (glycomacropeptide formula with docosahexaenoic acid and low phenylalanine) oral liquid, 237 mL bottle (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4808881000168115 | PKU Sphere20 oral liquid, 237 mL bottle | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| PKU Sphere20 oral liquid, 237 mL bottle | Is a | glycomacropeptide formula with docosahexaenoic acid and low phenylalanine oral liquid, 237 mL bottle | true | Inferred relationship | Some | ||
| PKU Sphere20 oral liquid, 237 mL bottle | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| PKU Sphere20 oral liquid, 237 mL bottle | Is a | PKU Sphere20 | true | Inferred relationship | Some | ||
| PKU Sphere20 oral liquid, 237 mL bottle | has manufactured dose form | oral liquid | true | Inferred relationship | Some | ||
| PKU Sphere20 oral liquid, 237 mL bottle | has intended active ingredient | glycomacropeptide formula with docosahexaenoic acid and low phenylalanine | true | Inferred relationship | Some | 2067928062 | |
| PKU Sphere20 oral liquid, 237 mL bottle | has unit of use | bottle | true | Inferred relationship | Some | 513828748 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| PKU Sphere20 oral liquid, 15 x 237 mL bottles | has TPUU | True | PKU Sphere20 oral liquid, 237 mL bottle | Inferred relationship | Some | 572156407 |
| PKU Sphere20 oral liquid, 15 x 237 mL bottles | has TPUU | True | PKU Sphere20 oral liquid, 237 mL bottle | Inferred relationship | Some | 949264461 |
Reference Sets
Trade product unit of use reference set
FHIR